134 related articles for article (PubMed ID: 27693619)
1. Inhibition of β-catenin signaling by phenobarbital in hepatoma cells in vitro.
Groll N; Petrikat T; Vetter S; Wenz C; Dengjel J; Gretzmeier C; Weiss F; Poetz O; Joos TO; Schwarz M; Braeuning A
Toxicology; 2016 Aug; 370():94-105. PubMed ID: 27693619
[TBL] [Abstract][Full Text] [Related]
2. Phenobarbital inhibits calpain activity and expression in mouse hepatoma cells.
Groll N; Kollotzek F; Goepfert J; Joos TO; Schwarz M; Braeuning A
Biol Chem; 2016 Jan; 397(1):91-6. PubMed ID: 26351921
[TBL] [Abstract][Full Text] [Related]
3. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.
Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M
Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046
[TBL] [Abstract][Full Text] [Related]
4. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
5. Activating and Inhibitory Functions of WNT/β-Catenin in the Induction of Cytochromes P450 by Nuclear Receptors in HepaRG Cells.
Thomas M; Bayha C; Vetter S; Hofmann U; Schwarz M; Zanger UM; Braeuning A
Mol Pharmacol; 2015 Jun; 87(6):1013-20. PubMed ID: 25824487
[TBL] [Abstract][Full Text] [Related]
6. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.
Giera S; Braeuning A; Köhle C; Bursch W; Metzger U; Buchmann A; Schwarz M
Toxicol Sci; 2010 May; 115(1):22-33. PubMed ID: 20118494
[TBL] [Abstract][Full Text] [Related]
7. β-catenin signaling, the constitutive androstane receptor and their mutual interactions.
Braeuning A; Pavek P
Arch Toxicol; 2020 Dec; 94(12):3983-3991. PubMed ID: 33097968
[TBL] [Abstract][Full Text] [Related]
8. Analysis of multiple nuclear receptor binding sites for CAR/RXR in the phenobarbital responsive unit of CYP2B2.
Zhang Q; Bae Y; Kemper JK; Kemper B
Arch Biochem Biophys; 2006 Jul; 451(2):119-27. PubMed ID: 16725103
[TBL] [Abstract][Full Text] [Related]
9. Regulation of gene expression by CAR: an update.
Kobayashi K; Hashimoto M; Honkakoski P; Negishi M
Arch Toxicol; 2015 Jul; 89(7):1045-55. PubMed ID: 25975989
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.
Li Q; Sun M; Wang M; Feng M; Yang F; Li L; Zhao J; Chang C; Dong H; Xie T; Chen J
Cancer Sci; 2021 May; 112(5):1695-1706. PubMed ID: 33605517
[TBL] [Abstract][Full Text] [Related]
11. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
[TBL] [Abstract][Full Text] [Related]
12. Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation.
Braeuning A; Heubach Y; Knorpp T; Kowalik MA; Templin M; Columbano A; Schwarz M
Toxicol Sci; 2011 Sep; 123(1):113-22. PubMed ID: 21705713
[TBL] [Abstract][Full Text] [Related]
13. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of β-catenin inhibitors and sorafenib in hepatoma cells.
Muche S; Kirschnick M; Schwarz M; Braeuning A
Anticancer Res; 2014 Sep; 34(9):4677-83. PubMed ID: 25202044
[TBL] [Abstract][Full Text] [Related]
16. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital.
Calvisi DF; Ladu S; Factor VM; Thorgeirsson SS
Carcinogenesis; 2004 Jun; 25(6):901-8. PubMed ID: 14742323
[TBL] [Abstract][Full Text] [Related]
17. Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotion.
Luisier R; Unterberger EB; Goodman JI; Schwarz M; Moggs J; Terranova R; van Nimwegen E
Nucleic Acids Res; 2014 Apr; 42(7):4180-95. PubMed ID: 24464994
[TBL] [Abstract][Full Text] [Related]
18. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.
Bai XL; Zhang Q; Ye LY; Liang F; Sun X; Chen Y; Hu QD; Fu QH; Su W; Chen Z; Zhuang ZP; Liang TB
Oncogene; 2015 Jul; 34(31):4089-97. PubMed ID: 25328135
[TBL] [Abstract][Full Text] [Related]
19. Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation.
Kim W; Khan SK; Yang Y
BMB Rep; 2017 Jan; 50(1):1-2. PubMed ID: 27881216
[TBL] [Abstract][Full Text] [Related]
20. Phenobarbital regulates nuclear expression of HNF-4alpha in mouse and rat hepatocytes independent of CAR and PXR.
Bell AW; Michalopoulos GK
Hepatology; 2006 Jul; 44(1):186-94. PubMed ID: 16799975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
